Nektar Therapeutics (NKTR) PT Raised to $99 at Jefferies
Tweet Send to a Friend
Jefferies analyst Roger Song raised the price target on Nektar Therapeutics (NASDAQ: NKTR) to $99.00 (from $69.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
